Translesional PRESSURE Measurements to Assess Clinical Relevance of a Mesenteric Artery Stenosis (PRESSURE-study)

Recruiting Observational Study
Chronic Mesenteric Ischemia Ischemia, Mesenteric
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
125 (estimated)
Sponsor
Erasmus Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Chronic mesenteric ischemia (CMI) is an incapacitating disease with a vast impact on quality of life due to severe abdominal pain after a meal, resulting in fear of eating and subsequent weight loss. CMI is most frequently caused by an atherosclerotic mesenteric artery stenosis, which is a frequent finding in the general population (6-29%). CMI is less prevalent due to an extensive collateral circ…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients with chronic mesenteric ischemia (CMI) and scheduled for endovascular procedure of the mesenteric arteries * Age ≥18 years of age * Patients who gave informed consent Exclusion Criteria: * Patients presenting with acute mesenteric ischemia * Common origin of the…
Contacts

Eva Karina Bocharewicz, PhD Candidate

+31652216196

e.bocharewicz@erasmusmc.nl

CONTACT